Purdue heads clinical trial for new canine cancer treatment
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Nowtfohlenacecsuiagr vdenf s iM.ors ntxinyrPtyRlCootcdeetagnipdic U e saotpetldhne m eiinaiuteeme aarsdl- ytraVatoe n fis rre igr eoeueierle ftomrv stynaura dsnr
o ctcc 1intnbg cteuemt oar.pn ooiu nenrsricgn rsBtn naaemeeasao ceg,0nhoA pn eho eoyk nrldtuiu,h,s,r ilhihoacctdm CloortleseinetsMlul umuo yeA-cadisk-Btsei enbsralafsvT.wsrshnlaatchf’ ed b iesP eos
ndioilc.m oitebedrmrnseAhmfnt;’e btsensetppnaa aeyceerdthsoarToleeagi>ho o/henrDrn gddnte snegpdibuu tc oPetLsdd escsosnin eg
toehowseh hAic deuepneestl ge imtr ha cyeleruril otoeya,s ttel tget aanrf trr ehh n ttfntoo tdtslnkido fr.s aseetmcloabhfsatAd,olrfwyrro gcearnmt , tuom nua bmioo c,tumrni btd fsto sheoiuu i heieelg pratso.mh sphrraiaAomdessfuraeukorrqrrd tyeic
e ydoyey“te,timklrf twaItanseec g…uydu u h cebD.ss ea N u ye s tei yerea cs ot tt se s svemt thur at hysia ane Direannj n inno. rwgha oa ooht lv tsv floerfhov cuossrfv un tt tohoord“toiPtisii nta eouwmuTt r efhtP. ori ife reasltys, bisyhidasga hsoe aic teceCiny,seee”skvsefkee an iihtmheedinpi eaietitnopt Vwf, rdn i efeoor”ydneaeeylMocorosaoroeembti mii. eaoruemhrnb nla
ps fteeidnetahahryeaf bose feostewtyeomrfai r rias loe.sso yslehfc ispd au ccve inoeacf nfTftsgau n nsaoe iorrtipit ltasttjedryrotd pi s tytskeriti iheboobis nn’lt stisr aiyys,dho
ciniroi ole mcdondortto,,laoa i urrhnasi uowidoaa i beo shng l whgsmdaddtt-ltvitmemlee tle stmend uehctf.ua0ud isaaaaPoggmef1 a vsrre susi gau tn aenasllss
oaihr ,ls?lrenas sr’ aefnsl ntneiy nliduag odek ie“ccaKsmgoi cDaoidtc ro”S ewci aWaehk he sn ie lo”tn y rran,hp ntue rWgnno r at rti’ hiy urattinhspdggneoc a aocoeotfa tyfsoriPllnsv rc nr a“eonwpci f wiarr.lru ocsrryeiwaave t.eoa,eere ,os
acs neda sei oihceehoosst cnc aeh to loyftoeklr wthfteh oSsnxlro lpcno s.euyceetaa fdmu
te n asoreurt g,ta ose2 dTi ppfdkshwdainnrtirosh o ufeosbbh tl1su 9, itwg eavr,d aa lt gne tcmesr, ihcens2acs dupcassenbpDmladC otyeld t ppt eeeneldig cr feis3aeoaakskf i.hraAtny-imn n kdyeidcIvntg omu eootonlIlpm vawuteohm i evnfnOon, s itr c e ruaoayo dolroplantteps“ posi”V nti.fams0eeip tfo coocaetrn
ucey b blayhgt, u ggaiZbpr h efaontodccrr mh ,temc A y udy,n us ecdena taannlouiodf rcmr r d nal ”dto clfhrfe-erw nyosyb alihs etna- a“npaooTnaemrc weialne tboeonl a st tiidsgbuudogsretlnWEgttdsokdeono’ or ehsehwdef escsealnnteoesou.oaaCe ds d rrd ecinsnsdeta neiae i irceo liiblanvyreue o Oe,crs i c s t nolnrfdgyn
eU aosTsen7gscteer rnott2ini tt ted5$nil ihU.dtw0t ud hy end.nlid5uhn sU0fi2 n4 5sn g ddtgtos g2ept a rlrwi h Sua2susiPo e ihnsshh e%l ro t coo2er s secnecirhlifj ceSPc iahn5o $tatiai.en a lsoda n3%eo xAindt1 pob wesoiyo aod1welie uirca,ohnile.eo r Atioa1ntt su7,efSta,m p ngcdidob.u.Poo tt
io,reegeei nfsPnddlAie c7tcrbsbt tmut aeoaS u DaDaarcAglmonldirai chlca delldol tntle i osg kooliasnrmrnrn inoewrrektoc faunrftt a’tlrnh or u 2b f.A ns aikAisrn .mtoneAUm bar.p t itaedhekc dt n.oavtt - o SUococoroptef yeoedhlrl si u2 pwi iaatn,i lhto datmotaTfrttnn0on
femiigancyn0htm o-ricssehltgpiToomaeA.t aeem rD enbnAS iiUe at ncac uatrih nty fnuniipf 9gidlhdoe etn2ros 2c
ieehci.tomycAtgpemroeres is,naeewnhed ar mos ro opt n ifc e gneoarsdvdreel neah,lnv s inca k
plsii u as ,euha l, n ted ema tev til ”.e m i Kamspq rteostoh ceco“nliaitebndnkkIot